Drug Information

Drug General Information
Drug ID
D03MLA
Former ID
DNC012343
Drug Name
PT-302
Drug Type
Small molecular drug
Indication Discovery agent Phase 1 [522768]
Structure
Download
2D MOL

3D MOL
Formula
C12H12FN3S2
Canonical SMILES
C1=CC(=CC=C1CCNC(=S)NC2=NC=CS2)F
InChI
1S/C12H12FN3S2/c13-10-3-1-9(2-4-10)5-6-14-11(17)16-12-15-7-8-18-12/h1-4,7-8H,5-6H2,(H2,14,15,16,17)
InChIKey
WGSDLRNUZBUXDV-UHFFFAOYSA-N
PubChem Compound ID
3001164
Target and Pathway
Target(s) HIV-1 reverse transcriptase Target Info Inhibitor [534066]
References
Ref 522768ClinicalTrials.gov (NCT00964262) A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide. U.S. National Institutes of Health.
Ref 534066J Med Chem. 1995 Dec 8;38(25):4929-36.Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studiesof PETT analogs.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.